Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

301. [Home visits to patients with severe COPD]

[Home visits to patients with severe COPD] Ilt-hjemmebesog til patienter med svaer kronisk obstruktiv lungesygdom (KOL) - en medicinsk teknologivurdering [Home visits to patients with severe COPD] Ilt-hjemmebesog til patienter med svaer kronisk obstruktiv lungesygdom (KOL) - en medicinsk teknologivurdering [Home visits to patients with severe COPD] Hvenegaard A, Albaek J, Nielsen ML, Hansen J, Ringbaek T, Sorensen TH, Wurgler MW Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hvenegaard A, Albaek J, Nielsen ML, Hansen J, Ringbaek T, Sorensen TH, Wurgler MW. Ilt-hjemmebesog til patienter med svaer kronisk obstruktiv lungesygdom (KOL) - en medicinsk teknologivurdering. [Home visits to patients with severe COPD] Copenhagen: Danish Centre for Evaluation and Health Technology Assessment (DACEHTA). Volume 9(4). 2009 Authors' conclusions Overall

Health Technology Assessment (HTA) Database.2009

302. Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review

Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review O'Shea SD, Taylor NF (...) , Paratz JD CRD summary The authors concluded that short-term progressive resistance exercise can appreciably increase muscle strength in people with chronic obstructive pulmonary disease and this may carry over into daily activities. Evidence appeared to support the authors’ conclusions about muscle strength, but there was little evidence about daily activities. The multitude of outcomes made it difficult to interpret findings. Authors' objectives To evaluate current evidence on the effects

DARE.2009

303. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials

Smoking cessation interventions in COPD: a network meta-analysis of randomised trials Smoking cessation interventions in COPD: a network meta-analysis of randomised trials Smoking cessation interventions in COPD: a network meta-analysis of randomised trials Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA CRD summary This well-conducted review concluded that a small body of evidence suggested that smoking cessation counselling combined with nicotine replacement therapy was more (...) effective than other treatments in patients with chronic obstructive pulmonary disease, but that substantially more research is needed. These conclusions are likely to be reliable. Authors' objectives To rank order the effectiveness of smoking cessation interventions for patients with chronic obstructive pulmonary disease. Searching MEDLINE, EMBASE, LILACS (Latin American and Caribbean Health Sciences Literature), Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials

DARE.2009

304. Statins in COPD: a systematic review

Statins in COPD: a systematic review Statins in COPD: a systematic review Statins in COPD: a systematic review Janda S, Park K, FitzGerald JM, Etminan M, Swiston J CRD summary The review concluded that statins may have a beneficial effect in the treatment of COPD. This conclusion reflected the results of the review, but should be treated with caution due to a limited number of studies and flawed methodology. Authors' objectives To systematically review the effects of statin therapy on outcomes (...) of patients with Chronic Obstructive Pulmonary Disease. Searching MEDLINE, Excerpta Medica, PapersFirst and Cochrane Central Register of Controlled Trials (CENTRAL) were searched to December 2008. Search terms were reported. Bibliographies of retrieved articles were handsearched for additional material. Searching was limited to English-language articles. Study selection Randomised, double-blind, single-blind, placebo-controlled trials (RCTs), observational cohort (retrospective and prospective), case

DARE.2009

305. Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review

Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review Rodrigo (...) and efficacy of combined long-acting beta-agonists (LABAs) and inhaled corticosteroids compared with LABA monotherapy in adult patients with chronic pulmonary obstructive disorder (COPD). Searching MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from 1980 to 2009. Search terms were reported. Drug manufacturers were consulted for further details. Abstracts were excluded. There were no language restrictions. Study selection Randomised controlled trials (RCTS

DARE.2009

306. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 micrograms) in the treatment of COPD

Cost-effectiveness of fluticasone propionate/salmeterol (500/50 micrograms) in the treatment of COPD Cost-effectiveness of fluticasone propionate/salmeterol (500/50 micrograms) in the treatment of COPD Cost-effectiveness of fluticasone propionate/salmeterol (500/50 micrograms) in the treatment of COPD Earnshaw SR, Wilson MR, Dalal AA, Chambers MG, Jhingran P, Stanford R, Mapel DW Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED (...) . Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to estimate the cost-effectiveness of the combination of fluticasone propionate and salmeterol compared with no maintenance treatment in chronic obstructive pulmonary disease. The authors concluded that both the combination and salmeterol alone were cost-effective compared

NHS Economic Evaluation Database.2009

307. Use of dry powder inhalers in acute exacerbations of asthma and COPD

Use of dry powder inhalers in acute exacerbations of asthma and COPD Use of dry powder inhalers in acute exacerbations of asthma and COPD Use of dry powder inhalers in acute exacerbations of asthma and COPD Selroos O, Borgstrom L, Ingelf J CRD summary This review concluded that dry powder inhalers functioned equally as well as established therapies with other inhaler devices in patients with acute asthma or chronic obstructive pulmonary disease. Given poor reporting of the review process (...) and uncertainty over the quality of the included studies, the authors' conclusions should be interpreted with caution. Authors' objectives To assess the efficacy of dry powder inhalers compared with established therapies delivered by pressurised metered dose inhalers (pMDI) or nebulizers in treatment of acute asthma and chronic obstructive pulmonary disease (COPD), irrespective of rapid-acting β 2 -agonist used. Searching MEDLINE, EMBASE, BIOSIS Previews, Current Contents and an internal AstraZeneca database

DARE.2009

308. The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review

The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review Broekhuizen BD, Sachs AP, Oostvogels R, Hoes AW, Verheij TJ, Moons KG CRD summary This review concluded that there was insufficient evidence to assess (...) the value of history taking and physical examination for diagnosing chronic obstructive pulmonary disease. Given the paucity of studies, the authors' conclusions seem appropriate. However, the authors excluded non-English language studies and did not search specifically for unpublished studies, so the conclusions may not represent the entire evidence base. Authors' objectives To evaluate the diagnostic value of history taking and physical examination in recognising chronic obstructive pulmonary disease

DARE.2009

309. Associations between statins and COPD: a systematic review

Associations between statins and COPD: a systematic review Associations between statins and COPD: a systematic review Associations between statins and COPD: a systematic review Dobler CC, Wong KK, Marks GB CRD summary This review concluded that available evidence suggested statins may reduce morbidity and mortality in patients with chronic obstructive pulmonary disease, but that further research was needed to confirm these findings. Given the limitations of the evidence reported in the review (...) , the recommendation for further research appears appropriate. Authors' objectives To assess the evidence for disease modifying effects of statin treatment in patients with chronic obstructive pulmonary disease (COPD). Searching MEDLINE (1950 to Oct 2008) and EMBASE (1980 to Oct 2008) were searched. Search terms were reported. Bibliographies of identified publications were searched. Language was limited to English. Study selection Studies that reported clinical or laboratory outcome measurements in patients

DARE.2009

310. Current status of research on osteoporosis in COPD: a systematic review

Current status of research on osteoporosis in COPD: a systematic review Current status of research on osteoporosis in COPD: a systematic review Current status of research on osteoporosis in COPD: a systematic review Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA CRD summary This review assessed the effects of treatment of osteoporosis in chronic obstructive pulmonary disease patients, but found that there was no evidence available. Given the limited search (...) and the restriction to studies in English, it is possible that some studies may have been missed, but the authors' conclusion reflects the findings of the review. Authors' objectives To assess the prevalence and effects of treatment of osteoporosis in chronic obstructive pulmonary disease patients. Searching PubMed and the Cochrane Library were searched for studies in English from 1988 to April 2008; search terms were reported. Other potentially relevant articles were identified through searching references

DARE.2009

311. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature

Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review (...) of the English-language literature Sillen MJ, Speksnijder CM, Eterman RM, Janssen PP, Wagers SS, Wouters EF, Uszko-Lencer NH, Spruit MA CRD summary This well-conducted review concluded that despite the limited numbers, disparity in patient populations and variability in methodology, NMES looked promising as a means of rehabilitating patients with congestive heart failure and COPD. There was sufficient evidence to warrant larger prospective randomised controlled trials. These conclusions are likely

DARE.2009

312. Electrical stimulation and peripheral muscle function in COPD: a systematic review

Electrical stimulation and peripheral muscle function in COPD: a systematic review Electrical stimulation and peripheral muscle function in COPD: a systematic review Electrical stimulation and peripheral muscle function in COPD: a systematic review Roig M, Reid WD CRD summary The authors concluded that there was weak evidence of the effectiveness of electrical stimulation to improve lower limb muscle function in chronic obstructive pulmonary disease patients. These conclusions should (...) be interpreted with caution as they were based on a small number of very small studies and there was a possibility that relevant studies have been missed Authors' objectives To determine the effect of electrical stimulation on muscle function, muscle size, fibre characteristics and exercise performance in patients with chronic obstructive pulmonary disease (COPD). Searching Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, CINAHL, EMBASE, Web of Science, SPORTDiscus and PEDro were searched

DARE.2009

313. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study

(Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study aimed to evaluate the cost-effectiveness of the self-treatment of exacerbations within a self-management programme for patients with a clinical diagnosis of chronic obstructive pulmonary disease. The authors concluded that self

NHS Economic Evaluation Database.2009

314. A systematic review of integrated use of disease-management interventions in asthma and COPD

A systematic review of integrated use of disease-management interventions in asthma and COPD A systematic review of integrated use of disease-management interventions in asthma and COPD A systematic review of integrated use of disease-management interventions in asthma and COPD Lemmens KM, Nieboer AP, Huijsman R CRD summary This review examined the effectiveness of multiple interventions versus single interventions or usual care for management of asthma and chronic obstructive pulmonary (...) and chronic obstructive pulmonary diseases (COPD). Searching MEDLINE and The Cochrane Library were searched from 1995 to May 2008. Search terms were reported. Study selection Controlled studies and time series that evaluated effectiveness of multiple interventions versus single interventions or usual care in patients aged 16 years or over diagnosed with asthma or COPD were eligible for inclusion. Studies needed to provide details on clinical outcomes, quality of life, health care utilisation

DARE.2009

316. Self-monitored, home-based pulmonary rehab was non-inferior to outpatient, hospital-based rehab for COPD

Self-monitored, home-based pulmonary rehab was non-inferior to outpatient, hospital-based rehab for COPD Self-monitored, home-based pulmonary rehab was non-inferior to outpatient, hospital-based rehab for COPD | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Self-monitored, home-based pulmonary rehab was non-inferior to outpatient, hospital-based rehab for COPD Article Text Therapeutics Self-monitored, home-based pulmonary rehab was non-inferior to outpatient, hospital-based rehab for COPD Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2009

317. Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD

Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main (...) menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD Article Text Therapeutics Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD Statistics from Altmetric.com No Altmetric data available for this article. QUESTION In patients with stable

Evidence-Based Medicine (Requires free registration)2009

318. Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD

Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main (...) menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD Article Text Therapeutics Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD Free Statistics from Altmetric.com No Altmetric data available for this article. S Singh Dr S Singh, Wake Forest University School

Evidence-Based Medicine (Requires free registration)2009

319. Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications

Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications Article Text Therapeutics Tiotropium reduced exacerbations but not rate of FEV 1 decline in patients with COPD using other respiratory medications

Evidence-Based Medicine (Requires free registration)2009

320. Identifying COPD Patients Near Death

Identifying COPD Patients Near Death "Identifying COPD Patients Near Death" by Matthew T. Stark < > > > > > Title Author Date of Award 8-15-2009 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Rob Rosenow PharmD, OD Second Advisor Annjanette Sommers MS, PA-C Rights . Abstract Background: Chronic Obstructive Pulmonary Disease (COPD) is a progressive terminal illness that can hospitalize those with the affliction multiple times during its (...) evolution. COPD often also requires care in the Intensive Care Unit (ICU) and mechanical ventilation with or without intubation. The care provided to COPD patients at the end of their life is invasive and shows a high mortality rate despite full medical treatment. Some patients in the terminal stages of COPD may be aggressively treated with full medical care when their discomfort may be better assuaged by palliative care. There is a great need to identify those patients in the terminal stages of COPD so

Pacific University EBM Capstone Project2009